An article in the Brainerd Dispatch describes a new collaboration between members of the Minnesota Precision Medicine Collaborative (MPMC) and the Mille Lacs Band of Ojibwe; together, they will "investigate aspects of lung cancer and nicotine metabolism from commercial tobacco use that may be unique to the American Indian populations in Minnesota." As part of this effort, researchers will conduct two pilot studies, one on the rate of nicotine metabolism in members of the Band and one on a new approach to lung cancer treatment and early detection. Pamala Jacobson, one of the leaders of MPMC, emphasizes the need for researchers to take the time to establish authentic, honorable working relationships within communities affected by health disparities. "For precision medicine approaches to be effective, we have to know how to apply this exciting new science to all populations, not just healthcare systems in metropolitan areas or those serving high income patients," said Jacobson. "Conducting the needed research and implementing precision medicine to benefit the health of American Indians and other minority populations is a priority." In addition to Prof. Jacobson, Consortium chair Susan M. Wolf is also an MPMC leader. To learn more, click here.
Friday, May 11, 2018